A View LCS vs Zio XT ECG Monitoring System

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A, A View LCS, is an AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection. In contrast, Tool B, Zio XT ECG Monitoring System, offers a wearable biosensor for up to 14 days of continuous cardiac monitoring, focusing on arrhythmia detection and diagnosis. While both utilize AI in cardiology, their distinct modalities (CT imaging vs. wearable ECG) and primary diagnostic focuses make them suitable for different clinical applications.

Choose AVIEW LCS if…

Choose A View LCS if your practice requires an advanced AI-powered platform for comprehensive thoracic CT analysis, particularly for lung cancer screening programs. This tool is ideal for radiologists and pulmonologists needing automated detection, quantification, and reporting of lung nodules, emphysema, and coronary artery calcification from a single low-dose CT scan.

View AVIEW LCS →

Choose Zio XT ECG Monitoring System if…

Choose Zio XT ECG Monitoring System if you need a convenient and highly compliant solution for extended, continuous ambulatory cardiac monitoring to detect intermittent arrhythmias. This wearable biosensor is perfect for cardiologists and internal medicine specialists seeking accurate, AI-driven analysis of ECG data over several days without the encumbrance of traditional Holter monitors.

View Zio XT ECG Monitoring System →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS Zio XT ECG Monitoring System
Pricing Subscription or one-off payment Contact for pricing
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) Cloud-based (AWS EC2 platform), no on-premise hardware required.
FDA Status Cleared AI-estimated Yes AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Zio XT ECG Monitoring System

Tool B (Zio XT) demonstrates superior patient usability with its wearable, wire-free design, water resistance, and high reported patient compliance and satisfaction. While Tool A (A View LCS) offers flexibility in deployment for clinicians, Tool B's focus on patient comfort for extended monitoring provides a distinct advantage in overall usability for its target users.

Clinical Value

AVIEW LCS

Tool A (A View LCS) offers comprehensive clinical value by performing multi-disease analysis from a single low-dose CT scan, detecting lung cancer, emphysema, and coronary artery calcification. This integrated approach provides a broader diagnostic scope and aids in risk stratification across multiple specialties, offering a more extensive clinical impact than Tool B's focused cardiac arrhythmia detection.

Pricing & Value

Zio XT ECG Monitoring System

Tool B (Zio XT) provides greater transparency in its pricing, offering specific per-patient costs for the UK and US Medicare rates, along with relevant CPT codes. This clarity allows healthcare providers to better assess the financial implications and potential for reimbursement, whereas Tool A's pricing is only available upon contact.

Enterprise Readiness

AVIEW LCS

Tool A (A View LCS) offers superior enterprise readiness due to its diverse deployment options, including cloud-based, hybrid, locally on dedicated hardware, and locally virtualized solutions. This flexibility allows for seamless integration into a wider range of existing hospital IT infrastructures and security policies compared to Tool B's exclusively cloud-based deployment.

Innovation

Tie

Both tools demonstrate significant innovation in their respective fields. Tool A (A View LCS) innovates by providing comprehensive multi-disease analysis from a single CT scan, integrating advanced AI for image processing and quantification. Tool B (Zio XT) innovates with its patient-centric wearable design for extended, comfortable, and highly compliant cardiac monitoring, coupled with its deep-learned AI for accurate arrhythmia detection.

Support & Docs

Tie

Neither the provided structured facts nor general knowledge offer sufficient information to compare the support and documentation offerings of either tool. Without details on service level agreements, training programs, or available resources, a distinction cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS Zio XT ECG Monitoring System
Product Name A View LCS Zio XT ECG Monitoring System
Primary Function AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan. Wearable, single-lead ECG biosensor for up to 14 days of continuous cardiac monitoring, utilizing FDA-cleared AI and expert review for accurate arrhythmia detection and diagnosis.
Company Coreline Soft Co. iRhythm Technologies
Key Feature (Imaging/Monitoring) Automated lung nodule detection and classification Continuous ambulatory cardiac monitoring for up to 14 days
Key Feature (Analysis/Hardware) Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass) Wearable single-lead ECG biosensor (Zio biosensor)
Specialties Cardiology, Pulmonology, Radiology Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and Zio XT ECG Monitoring System.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection, serving Cardiology, Pulmonology, and Radiology. Zio XT ECG Monitoring System offers continuous cardiac monitoring for up to 14 days for arrhythmia detection and diagnosis, primarily for Cardiology, Emergency Medicine, and Internal Medicine.
AVIEW LCS utilizes AI for automated lung nodule detection and classification, nodule volume quantification, emphysema analysis, and coronary artery calcium scoring from CT scans. Zio XT employs a proprietary, FDA-cleared deep-learned AI algorithm for analyzing ECG data to detect and diagnose arrhythmias, complemented by expert review.
AVIEW LCS analyzes existing CT scans, so patient interaction is primarily related to the imaging procedure itself. The Zio XT system involves a wearable single-lead ECG biosensor that patients wear for up to 14 days for continuous ambulatory cardiac monitoring, and it includes a patient-activated button for symptomatic event logging.
AVIEW LCS offers automated comprehensive report generation in PDF, DICOM PDF, and SR formats, including Lung-RADS scoring and reporting. Zio XT provides data analysis and reporting through its cloud-based software platform (ZEUS) for arrhythmia detection and diagnosis.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.